Croda International PLC (GB:CRDA)
LSE:CRDA
Holding GB:CRDA?
Track your performance easily

Croda International (CRDA) Income Statement

72 Followers

Croda International Income Statement

Last quarter (Q4 2022), Croda International's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Croda International's net income was £―. See Croda International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-£ 1.69B£ 2.09B£ 1.89B£ 1.39B£ 1.38B
Cost of Revenue
-£ 964.50M£ 1.10B£ 950.70M£ 758.20M£ 746.50M
Gross Profit
-£ 730.00M£ 985.60M£ 938.90M£ 632.10M£ 631.20M
Operating Expense
-£ 482.50M£ 540.90M£ 503.20M£ 342.10M£ 311.30M
Operating Income
-£ 247.50M£ 444.70M£ 435.70M£ 290.00M£ 319.90M
Net Non Operating Interest Income Expense
-£ -11.20M£ -20.70M£ 24.20M£ 20.50M£ 17.60M
Other Income Expense
--£ -356.00M---
Pretax Income
-£ 236.30M£ 424.00M£ 411.50M£ 269.50M£ 302.30M
Tax Provision
-£ 64.20M£ 126.70M£ 88.70M£ 67.90M£ 78.50M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ 171.00M£ 293.30M£ 320.80M£ 201.60M£ 223.90M
Basic EPS
-£ 1.22£ 4.66£ 2.30£ 1.55£ 1.73
Diluted EPS
-£ 1.22£ 4.65£ 2.30£ 1.55£ 1.72
Basic Average Shares
-£ 139.60M£ 139.40M£ 139.50M£ 130.00M£ 129.60M
Diluted Average Shares
-£ 139.80M£ 139.70M£ 139.80M£ 130.20M£ 129.90M
Dividend Per Share
-£ 0.62£ 0.61£ 0.95£ 0.90£ 0.90
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-£ 1.45B£ 1.64B£ -1.45B£ -1.10B£ -1.06B
Net Income From Continuing And Discontinued Operation
-£ 171.00M£ 293.30M£ 320.80M£ 201.60M£ 223.90M
Normalized Income
-£ 177.22M£ 343.44M£ 329.42M£ 234.29M£ 255.86M
Interest Expense
------
EBIT
-£ 262.20M£ 448.00M£ 437.20M£ 290.50M£ 320.80M
EBITDA
-£ 388.40M£ 568.70M£ 550.50M£ 290.50M£ 320.80M
Currency in GBP

Croda International Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis